No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
10-Q: Q3 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
Express News | Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq
10-Q: Q2 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results